atorvastatin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
atorvastatin — decreases C-reactive protein concentration
Evidence strength: moderate.Finding“CRP levels decreased significantly in both groups, though the magnitude of reduction was substantially greater in the atorvastatin group (p < 0.001), resulting in a highly significant between-group difference at 6 months (p < 0.001).”
Quoted verbatim from Atorvastatin reduces recurrent decompensation events in advanced cirrhosis in a randomized placebo-controlled trial.. - Study
- RCT
- Dose
- 20 mg once daily
- Population
- Adults aged 18-75 with decompensated liver cirrhosis, atorvastatin 20 mg daily versus placebo for six months, both arms continuing standard-of-care therapies
Atorvastatin reduces recurrent decompensation events in advanced cirrhosis in a randomized placebo-controlled trial.2026PMID:4186506910.1038/s41598-026-41326-4Permalink
To cite this finding: https://catalystproject.ai/e/01M5JCHTS5NSPTHMWDRTAPQD8T